Cargando…
Synthesis and Biological Evaluation of Cardiac Glycosides for Cancer Therapy by Targeting the DNA Damage Response
Cardiac glycosides (CGs) are bioactive compounds originally used to treat heart diseases, but recent studies have demonstrated their anticancer activity. We previously demonstrated that Antiaris toxicaria 2 (AT2) possesses anticancer activity in KRAS mutated lung cancers via impinging on the DNA dam...
Autores principales: | Ainembabazi, Diana, Geng, Xinran, Gavande, Navnath S., Turchi, John J., Zhang, Youwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637767/ https://www.ncbi.nlm.nih.gov/pubmed/36054918 http://dx.doi.org/10.1002/cmdc.202200415 |
Ejemplares similares
-
The mechanistic role of cardiac glycosides in DNA damage response and repair signaling
por: Ainembabazi, Diana, et al.
Publicado: (2023) -
Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks
por: Mendoza-Munoz, Pamela L, et al.
Publicado: (2023) -
Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair
por: Kelm, Jeremy M., et al.
Publicado: (2022) -
In Vivo Targeting Replication Protein A for Cancer Therapy
por: VanderVere-Carozza, Pamela S., et al.
Publicado: (2022) -
PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
por: Kelm, Jeremy M., et al.
Publicado: (2023)